BNP Paribas Financial Markets
RDY icon

BNP Paribas Financial Markets’s Dr. Reddy's Laboratories RDY Stock Holding History

BNP Paribas Financial Markets’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.4M Sell
2,649,866
-534,105
-17% -$7.21M 0.01% 889
2026
Q1 		$44.1M Sell
3,183,971
-968,595
-23% -$13.5M 0.02% 740
2025
Q4 		$58.3M Buy
4,152,566
+149,384
+4% +$2.1M 0.03% 609
2025
Q3 		$56M Sell
4,003,182
-10,710
-0.3% -$154K 0.03% 585
2025
Q2 		$60.3M Sell
4,013,892
-569,441
-12% -$8.13M 0.03% 496
2025
Q1 		$60.5M Buy
4,583,333
+1,682,363
+58% +$23.2M 0.04% 516
2024
Q4 		$45.8M Buy
2,900,970
+853,770
+42% +$12.8M 0.03% 654
2024
Q3 		$32.5M Buy
2,047,200
+481,695
+31% +$7.75M 0.02% 667
2024
Q2 		$23.9M Buy
1,565,505
+1,049,210
+203% +$15M 0.02% 692
2024
Q1 		$7.57M Buy
516,295
+164,790
+47% +$2.41M 0.01% 1209
2023
Q4 		$4.89M Sell
351,505
-4,730
-1% -$63.2K 0.01% 1419
2023
Q3 		$4.76M Buy
356,235
+2,475
+0.7% +$33.5K 0.01% 1306
2023
Q2 		$4.47M Sell
353,760
-6,880
-2% -$80.3K 0.01% 1294
2023
Q1 		$4.11M Sell
360,640
-2,670
-0.7% -$28.8K 0.01% 1362
2022
Q4 		$3.76M Sell
363,310
-1,870
-0.5% -$20.2K 0.01% 1453
2022
Q3 		$3.82M Buy
365,180
+25,190
+7% +$268K 0.01% 1507
2022
Q2 		$3.77M Sell
339,990
-5,580
-2% -$60.7K 0.01% 1375
2022
Q1 		$3.85M Sell
345,570
-17,870
-5% -$203K 0.01% 1433
2021
Q4 		$4.75M Buy
363,440
+169,575
+87% +$2.14M 0.01% 1377
2021
Q3 		$2.53M Sell
193,865
-2,860
-1% -$38.1K ﹤0.01% 1728
2021
Q2 		$2.89M Sell
196,725
-4,045
-2% -$56.6K ﹤0.01% 1570
2021
Q1 		$2.47M Sell
200,770
-13,575
-6% -$174K ﹤0.01% 1545
2020
Q4 		$3.06M Sell
214,345
-119,675
-36% -$1.61M 0.01% 1407
2020
Q3 		$4.65M Sell
334,020
-7,945
-2% -$94.7K 0.01% 1114
2020
Q2 		$3.63M Sell
341,965
-4,140
-1% -$42.1K 0.01% 1218
2020
Q1 		$2.79M Sell
346,105
-10,765
-3% -$89.8K 0.01% 1292
2019
Q4 		$2.9M Sell
356,870
-41,260
-10% -$326K 0.01% 1495
2019
Q3 		$3.02M Sell
398,130
-33,700
-8% -$251K 0.01% 1294
2019
Q2 		$3.24M Buy
431,830
+2,095
+0.5% +$16.5K 0.01% 1237
2019
Q1 		$3.48M Sell
429,735
-14,510
-3% -$110K 0.01% 1144
2018
Q4 		$3.35M Sell
444,245
-1,380
-0.3% -$9.71K 0.01% 1089
2018
Q3 		$3.08M Sell
445,625
-211,690
-32% -$1.41M ﹤0.01% 1326
2018
Q2 		$4.23M Buy
657,315
+7,725
+1% +$48.7K 0.01% 1198
2018
Q1 		$4.25M Buy
649,590
+41,130
+7% +$288K 0.01% 1074
2017
Q4 		$4.57M Buy
608,460
+236,640
+64% +$1.7M 0.01% 1073
2017
Q3 		$2.65M Sell
371,820
-105,615
-22% -$759K 0.01% 1014
2017
Q2 		$4.02M Sell
477,435
-31,195
-6% -$254K 0.01% 863
2017
Q1 		$4.08M Sell
508,630
-85,100
-14% -$735K 0.01% 825
2016
Q4 		$5.38M Buy
593,730
+234,000
+65% +$2.18M 0.03% 537
2016
Q3 		$3.34M Sell
359,730
-17,890
-5% -$171K 0.01% 560
2016
Q2 		$3.87M Sell
377,620
-4,790
-1% -$43.9K 0.02% 566
2016
Q1 		$3.46M Sell
382,410
-382,030
-50% -$3.41M 0.01% 676
2015
Q4 		$7.08M Buy
764,440
+284,215
+59% +$3.11M 0.02% 539
2015
Q3 		$6.14M Buy
480,225
+441,350
+1,135% +$5.48M 0.02% 576
2015
Q2 		$430K Sell
38,875
-34,490
-47% -$381K ﹤0.01% 1398
2015
Q1 		$838K Sell
73,365
-8,480
-10% -$90K ﹤0.01% 1155
2014
Q4 		$826K Sell
81,845
-35,565
-30% -$374K ﹤0.01% 1004
2014
Q3 		$1.23M Sell
117,410
-17,090
-13% -$161K ﹤0.01% 1176
2014
Q2 		$1.16M Sell
134,500
-50,005
-27% -$421K ﹤0.01% 1145
2014
Q1 		$1.66M Buy
184,505
+29,595
+19% +$257K ﹤0.01% 965
2013
Q4 		$1.27M Sell
154,910
-483,340
-76% -$3.83M ﹤0.01% 998
2013
Q3 		$4.82M Buy
638,250
+433,080
+211% +$3.15M ﹤0.01% 707
2013
Q2 		$1.55M Buy
+205,170
New +$1.5M ﹤0.01% 821

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BNP Paribas Financial Markets's RDY Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Dr. Reddy's Laboratories (RDY) stake by 17% in Q2 2026, selling an estimated $7.21M and leaving 2,649,866 shares worth $38.4M. The position accounts for 0.01% of the portfolio, ranked #889.

BNP Paribas Financial Markets first reported a position in RDY in Q2 2013 and has held it in 53 quarters since. The position peaked at $60.5M in Q1 2025. 211 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • BNP Paribas Financial Markets held 2,649,866 shares of Dr. Reddy's Laboratories worth $38.4M as of Q2 2026.
  • BNP Paribas Financial Markets sold 534,105 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $7.21M.
  • Dr. Reddy's Laboratories made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #889 holding.
  • BNP Paribas Financial Markets first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 53 quarters since.
  • BNP Paribas Financial Markets's Dr. Reddy's Laboratories position peaked at $60.5M in Q1 2025.
  • 211 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.